Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D, Zimmermann A, Aronson D, Childs M, Widing E, Laithier V, Plaschkes J, Pritchard J, Scopinaro M, MacKinlay G, Czauderna P. Perilongo G, et al. Among authors: brock p. N Engl J Med. 2009 Oct 22;361(17):1662-70. doi: 10.1056/NEJMoa0810613. N Engl J Med. 2009. PMID: 19846851 Free article. Clinical Trial.
Ototoxicity of high-dose cis-platinum in children.
Brock P, Pritchard J, Bellman S, Pinkerton CR. Brock P, et al. Med Pediatr Oncol. 1988;16(5):368-9. doi: 10.1002/mpo.2950160517. Med Pediatr Oncol. 1988. PMID: 3185367 No abstract available.
Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J. Perilongo G, et al. Among authors: brock p. Cancer. 2000 Oct 15;89(8):1845-53. doi: 10.1002/1097-0142(20001015)89:8<1845::aid-cncr27>3.0.co;2-d. Cancer. 2000. PMID: 11042582 Clinical Trial.
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J. Pritchard J, et al. Among authors: brock p. J Clin Oncol. 2000 Nov 15;18(22):3819-28. doi: 10.1200/JCO.2000.18.22.3819. J Clin Oncol. 2000. PMID: 11078495 Clinical Trial.
Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
Perilongo G, Shafford E, Maibach R, Aronson D, Brugières L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte JB, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J; International Society of Paediatric Oncology-SIOPEL 2. Perilongo G, et al. Among authors: brock p. Eur J Cancer. 2004 Feb;40(3):411-21. doi: 10.1016/j.ejca.2003.06.003. Eur J Cancer. 2004. PMID: 14746860 Clinical Trial.
289 results